Non-vitamin K antagonist oral anticoagulants (NOACs) in cancer patients with atrial fibrillation
Non-vitamin K antagonist oral anticoagulants (NOACs), or direct oral anticoagulants have not been tested in randomized trials conducted in patients with atrial fibrillation (AF), who had malignant disease. However, their use in cancer patients increases and real-life evidence for their effectiveness...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
KARE Publishing
2019-12-01
|
| Series: | Anatolian Journal of Cardiology |
| Subjects: | |
| Online Access: | https://jag.journalagent.com/z4/download_fulltext.asp?pdir=anatoljcardiol&un=AJC-30766 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850239245489274880 |
|---|---|
| author | Anetta Undas Leszek Drabik |
| author_facet | Anetta Undas Leszek Drabik |
| author_sort | Anetta Undas |
| collection | DOAJ |
| description | Non-vitamin K antagonist oral anticoagulants (NOACs), or direct oral anticoagulants have not been tested in randomized trials conducted in patients with atrial fibrillation (AF), who had malignant disease. However, their use in cancer patients increases and real-life evidence for their effectiveness and safety in this vulnerable subset of patients is growing. The challenges of the use of NOACs in cancer patients with AF and the current expert opinions on this subject have been summarized in this review article. |
| format | Article |
| id | doaj-art-1e88a4b4c6924c5d924979d6ea3a9d8a |
| institution | OA Journals |
| issn | 2149-2263 |
| language | English |
| publishDate | 2019-12-01 |
| publisher | KARE Publishing |
| record_format | Article |
| series | Anatolian Journal of Cardiology |
| spelling | doaj-art-1e88a4b4c6924c5d924979d6ea3a9d8a2025-08-20T02:01:13ZengKARE PublishingAnatolian Journal of Cardiology2149-22632019-12-01231101810.14744/AnatolJCardiol.2019.30766AJC-30766Non-vitamin K antagonist oral anticoagulants (NOACs) in cancer patients with atrial fibrillationAnetta Undas0Leszek Drabik1John Paul II Hospital, Krakow, PolandJohn Paul II Hospital, Krakow, PolandNon-vitamin K antagonist oral anticoagulants (NOACs), or direct oral anticoagulants have not been tested in randomized trials conducted in patients with atrial fibrillation (AF), who had malignant disease. However, their use in cancer patients increases and real-life evidence for their effectiveness and safety in this vulnerable subset of patients is growing. The challenges of the use of NOACs in cancer patients with AF and the current expert opinions on this subject have been summarized in this review article.https://jag.journalagent.com/z4/download_fulltext.asp?pdir=anatoljcardiol&un=AJC-30766anticoagulationatrial fibrillationbleedingcancerdirect oral anticoagulants |
| spellingShingle | Anetta Undas Leszek Drabik Non-vitamin K antagonist oral anticoagulants (NOACs) in cancer patients with atrial fibrillation Anatolian Journal of Cardiology anticoagulation atrial fibrillation bleeding cancer direct oral anticoagulants |
| title | Non-vitamin K antagonist oral anticoagulants (NOACs) in cancer patients with atrial fibrillation |
| title_full | Non-vitamin K antagonist oral anticoagulants (NOACs) in cancer patients with atrial fibrillation |
| title_fullStr | Non-vitamin K antagonist oral anticoagulants (NOACs) in cancer patients with atrial fibrillation |
| title_full_unstemmed | Non-vitamin K antagonist oral anticoagulants (NOACs) in cancer patients with atrial fibrillation |
| title_short | Non-vitamin K antagonist oral anticoagulants (NOACs) in cancer patients with atrial fibrillation |
| title_sort | non vitamin k antagonist oral anticoagulants noacs in cancer patients with atrial fibrillation |
| topic | anticoagulation atrial fibrillation bleeding cancer direct oral anticoagulants |
| url | https://jag.journalagent.com/z4/download_fulltext.asp?pdir=anatoljcardiol&un=AJC-30766 |
| work_keys_str_mv | AT anettaundas nonvitaminkantagonistoralanticoagulantsnoacsincancerpatientswithatrialfibrillation AT leszekdrabik nonvitaminkantagonistoralanticoagulantsnoacsincancerpatientswithatrialfibrillation |